Precision-synthesized active ingredients and biological solutions manufactured under strict international quality control protocols.
An in-depth analysis of chemical synthesis, blood-brain barrier permeability optimization, and regulatory compliance paradigms for enterprise B2B buyers.
The global demand for high-efficacy neurological drugs and active pharmaceutical ingredients (APIs) targeting Central Nervous System (CNS) disorders is undergoing unprecedented expansion. Characterized by complex pathological mechanisms, neurodegenerative diseases (such as Alzheimer’s disease, Parkinson’s disease, and Amyotrophic Lateral Sclerosis), epilepsy, neuropathic pain, and neuro-psychiatric conditions require exceptionally rigorous synthesis standards and chemical precision.
From a bio-pharmacological perspective, manufacturing neurological APIs demands specialized chemical routes optimized for physiological targets including GABAergic receptors, NMDA receptors, dopamine transporters, serotonin pathways, and voltage-gated ion channels. High-purity intermediates form the structural backbone of these advanced drugs. Achieving high enantiomeric excess (ee), minimal impurity profiles (below ICH Q3A/B guidelines), and consistent polymorphism properties is critical to ensuring optimal lipophilicity and molecular crossing of the Blood-Brain Barrier (BBB).
China has firmly established itself as the global nexus for chemical synthesis, custom contract R&D (CRO/CDMO), and bulk pharmaceutical intermediate production. For global enterprise buyers seeking contract manufacturing for neurological formulations, partnering with tier-one Chinese chemical enterprises provides undeniable technical and operational advantages:
Direct access to fundamental basic chemical building blocks minimizes raw material price volatility and guarantees unbroken production schedules even during global trade disruptions.
State-of-the-art synthetic techniques including asymmetric hydrogenation, enzymatic biocatalysis, and continuous flow chemistry ensure superior yield and ultra-pure stereoisomeric structures.
Large-scale multi-ton reaction vessels coupled with streamlined manufacturing processes lower the unit production cost of complex APIs and advanced intermediates significantly.
A trusted leader in Active Pharmaceutical Ingredients, intermediates, technology transfer, and international supply chain solutions.
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Drugs and intermediates are widely used in the following aspects (partial):
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization.
For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
Empowering pharmaceutical brands worldwide with regulatory dossier filings, site audits, and rigorous analytical quality control.
We provide comprehensive Drug Master File (DMF) submissions, Certificate of Suitability (CEP/COS) document packages, and CTD-format dossiers to support your national health authority approvals across the US FDA, EMA, NMPA, PMDA, and MFDS.
Every production batch undergoes complete spectroscopic validation, including 1H/13C NMR, LC-MS/MS, High-Performance Liquid Chromatography (HPLC) assay, residual solvent analysis (GC-headspace), and heavy metal limit testing per ICH guidelines.
With strong commercial infrastructure in Southeast Asia, South Korea, Japan, and India, we offer end-to-end consulting for product registration, local distributor authorization, and customs clearance protocols for overseas clients.
| Compliance Parameter | Standard Market Requirement | Hangzhou Jeci Biochem Capability | Impact on Procurement |
|---|---|---|---|
| Impurity Profiling (ICH Q3A/B) | Specified Unknowns < 0.10% | Ultra-Low Single Unknowns < 0.05% | Accelerated NDA/ANDA Approval Risk Reduction |
| GMP & Audit Readiness | Local Country GMP Verification | cGMP Compliant Facilities & Remote Audit Ready | Seamless On-Site Quality Verification |
| Batch Consistency | RSD Assay < 2.0% | RSD Assay < 0.5% (Multi-batch verification) | Minimizes Batch-to-Batch Formulating Variance |
| Supply Chain Traceability | Single-tier Origin Tracking | Full Upstream Intermediate Auditing | Protects Against Raw Material Shortages |
Tailored OEM, CDMO, and wholesale supply chain contracts designed for global drug manufacturers, biotech institutions, and veterinary health distributors.
From milligram-scale R&D pilot batches to multi-ton industrial scale production. Our collaborative research centers in China specialize in difficult chemical reactions including chiral resolution, cryogenic reactions, and high-pressure hydrogenation.
We mitigate global trade uncertainties by maintaining strategic reserves of key starting materials (KSMs) and offering flexible lead times, FOB/CIF/DDP international shipping terms, and temperature-controlled logistics for sensitive biologicals.
Our expertise extends beyond raw chemical delivery. We offer full technology transfer consulting, helping overseas pharmaceutical manufacturers set up localized formulation pipelines with validated batch manufacturing records (BMR).
Bridging human central nervous system pharmacology, veterinary neuro-care, diagnostics, and functional neuro-nutraceuticals.
Advanced synthetic intermediates for targeted neurological anti-neoplastic drugs (such as Tyrosine Kinase Inhibitors like Dasatinib Monohydrate), anti-epileptics, anxiolytics, and novel neuroprotective therapeutics entering Phase II/III clinical trials.
Neurological signaling in parasites and livestock requires targeted veterinary formulations. Active ingredients like Levamisole interact with cholinergic nerve ganglia, offering selective neuro-toxicity to endoparasites while remaining safe for host animals.
Pharmaceutical-grade biochemical nutrients, including high-bioavailability Magnesium formulations and neuro-supportive Vitamin B12 complexes, play a vital role in modulating neurotransmitter synthesis, sleep quality, and physiological stress responses.
The neurological drug sector is rapidly shifting toward personalized medicine. Early stage diagnostic kits (such as medical-grade urinalysis strips and FOB cassette devices) allow clinicians and veterinarians to monitor systemic biochemical balances and organ function prior to administering intensive neurological pharmacotherapies. Combining high-precision APIs with diagnostic markers ensures higher therapeutic indices and reduced adverse drug reactions (ADRs).
Detailed insights on custom manufacturing, quality management systems, regulatory documentation, and international shipping.
Hangzhou Jeci Biochem Technology operates in full alignment with international cGMP and ISO 9001 certification frameworks. Our partner manufacturing sites utilize automated reaction control systems, validated water purification systems (WFI), and controlled cleanroom environments (Class 100,000 / ISO Class 8). All batch outputs undergo stringent HPLC, GC, NMR, and heavy metal testing backed by comprehensive Certificates of Analysis (COA).
Yes. We offer complete regulatory support, providing Drug Master Files (DMF) in eCTD format, Certificates of Suitability (CEP), technical open/closed parts, and stability test data according to ICH Q1A(R2) conditions. Our regulatory team directly assists clients in registering APIs with health authorities across Southeast Asia, Europe, South America, India, and North America.
In collaboration with domestic drug research institutes and high-tech manufacturing plants, we provide custom chemical synthesis from gram scale to multi-ton commercial volumes. Our expertise covers asymmetric synthesis, heterocyclic compounds, complex pharmaceutical intermediates, multi-step organometallic reactions, and technology transfer consulting.
We offer full international supply chain logistics under FOB, CIF, CFR, and DDP terms. For temperature-sensitive APIs, diagnostic devices, and live vaccines (such as poultry vaccines), we utilize temperature-monitored refrigerated containers (2-8°C or ultra-deep freeze) with real-time IoT data loggers to ensure uncompromised product efficacy upon arrival.
Our strategic catalog includes human APIs and intermediates (e.g., Dasatinib Monohydrate), veterinary drugs and formulations (Levamisole, Enrofloxacin), biological hormones, poultry vaccines, pet nutritional supplements (Vitamin B12, Probiotics, Magnesium tablets), diagnostic test cassettes (FOB, Urinalysis), and industrial chemical raw materials.
Explore our secondary lineup of specialized active raw materials, veterinary care formulations, and diagnostic tools.
SJ medical
